Medicine & Pharmaceuticals 

Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Company's Board of Directors (the "Board"), following careful review and consultation with its independent financial and legal advisors, has...

Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders
Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma

Researchers at the National Institutes of Health (NIH) have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no...

Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma
UPSHER-SMITH WINS HDA DIANA AWARD

Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has been awarded a Distribution Industry Award for Notable Achievement in Healthcare (DIANA Award) for "Best Overall Manufacturer, Branded...

UPSHER-SMITH WINS HDA DIANA AWARD
Phoenix Children's Research Institute Study Identifies FOXF1 Enhancers Involved in Rare Lung Disease

According to a study published in Nature Communications, research conducted at the Phoenix Children's Research Institute at the University of Arizona College of Medicine - Phoenix, shows how frequent non-coding FOXF1...

Phoenix Children's Research Institute Study Identifies FOXF1 Enhancers Involved in Rare Lung Disease
Smokey Point Behavioral Hospital Expands Services and Capacity

Smokey Point Behavioral Hospital announced the addition of 30 new beds, which will allow for an expansion of substance abuse programs, including detoxification and dual diagnosis, and adolescent services.

Smokey Point Behavioral Hospital Expands Services and Capacity
4WEB Medical Announces Commercial Launch of its Cervical Spine Integrated Plating Solution

4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technology™, announced the initial launch of the newest addition to the company's...

4WEB Medical Announces Commercial Launch of its Cervical Spine Integrated Plating Solution
American Academy of Ambulatory Care Nursing and the Commission for Nurse Reimbursement Announce Strategic Partnership to Advance Nursing Value and Revenue Generation

The American Academy of Ambulatory Care Nursing (AAACN) and the Commission for Nurse Reimbursement (CNR) unveiled a landmark strategic partnership. This alliance focuses on advancing and implementing nursing value...

American Academy of Ambulatory Care Nursing and the Commission for Nurse Reimbursement Announce Strategic Partnership to Advance Nursing Value and Revenue Generation
Results of Woolsey Pharmaceuticals' Phase 2a Study of BRAVYL in ALS Patients Shows Statistically Significant Reduction in Neurofilament Light and Directionally Improved Clinical Outcomes

Woolsey Pharmaceuticals, a clinical-stage drug development company, announced that its investigational drug, CIRARA, was well tolerated and exhibited statistically significant reductions in a key biomarker, Neurofilament...

Results of Woolsey Pharmaceuticals' Phase 2a Study of BRAVYL in ALS Patients Shows Statistically Significant Reduction in Neurofilament Light and Directionally Improved Clinical Outcomes
CMT Research Foundation Invests in ReviR Therapeutics Research to Pioneer Small Molecule Therapeutics for CMT1A

The CMT Research Foundation, a non-profit focused solely on delivering treatments and cures for Charcot-Marie-Tooth disease (CMT)*, has formed a strategic partnership with ReviR Therapeutics to advance small molecule...

CMT Research Foundation Invests in ReviR Therapeutics Research to Pioneer Small Molecule Therapeutics for CMT1A
Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, today announced that the National Medical Products Administration of China has...

Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma
Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health

Recently, Professor Jianping Weng of the University of Science and Technology of China (USTC) and President of Anhui Medical University and his team of researchers from USTC, Southern Medical University and Peking...

Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health
Ping An Announces Brand Upgrade of "Ping An Family Doctor"

The "Ping An Family Doctor Brand Upgrade Conference" was held in Shanghai recently. Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318 / 82318; SSE: 601318) has upgraded its...

Ping An Announces Brand Upgrade of "Ping An Family Doctor"
Smartee Presents Two Decades of Progress at the 99th EOS Congress in Athens

Smartee Denti-Technology, a pioneer in clear aligner industry with 20 years of independent research & development and over 850 patents applied, shared its two decades of achievement and full series of products at the...

Smartee Presents Two Decades of Progress at the 99th EOS Congress in Athens
Innovent Reports Oncology Pipeline Updates at Investor Meeting

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic,...

Innovent Reports Oncology Pipeline Updates at Investor Meeting
Micro Medical Solutions Achieves Milestone with 200th Enrollment in HEAL Registry

Micro Medical Solutions -- Micro Medical Solutions, a leader in providing innovative medical device solutions, is excited to announce that it has achieved a major milestone with the enrollment of its 200th patient in the...

Micro Medical Solutions Achieves Milestone with 200th Enrollment in HEAL Registry
AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024

Amgen (NASDAQ:AMGN) today announced the presentation of data across its diverse portfolio and pipeline at the European Alliance of Associations for Rheumatology's (EULAR) 2024 Congress, June 12-15 in Vienna. The 27...

AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024
NABH Comments on the Critical Role of Youth Residential Treatment Facilities

The National Association for Behavioral Healthcare recognizes the longstanding good work of its members to provide quality – and often life-saving – care to America's children and youth in residential treatment...

NABH Comments on the Critical Role of Youth Residential Treatment Facilities
Mindpath Health releases Celebrating Pride Month: What Happens After You Come Out

It's June, meaning Pride Month events are happening all over the U.S. For many members of the LGBTQIA+ community, it can be a time to celebrate, enjoy closeness within the community, and organize to fight for rights....

Mindpath Health releases Celebrating Pride Month: What Happens After You Come Out
Hospice Nurse with 3 Million Social Media Followers Partners with Medical Device Company

"Hospice Nurse Julie" and Hospi Corporation–the maker of the Macy Catheter–are pleased to announce their partnership.

Hospice Nurse with 3 Million Social Media Followers Partners with Medical Device Company
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a limited market release of its new VASCADE MVP® XL...

Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device
FDA Roundup: June 18, 2024

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:

FDA Roundup: June 18, 2024
Indivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Ca

Indivior PLC (LSE/Nasdaq: INDV) today announced the publication of a modeling study in Frontiers in Psychiatry that predicts OPVEE (nalmefene) nasal spray (2.7 mg nalmefene, equivalent to 3 mg of nalmefene hydrochloride)...

Indivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Ca
MEADOWS BEHAVIORAL HEALTHCARE TAPS EXPERIENCED CLINICIAN AND LEADER JAIME VINCK TO FILL PRESIDENT'S SEAT

Meadows Behavioral Healthcare is excited to announce Jaime Vinck, MC, LPC, has been named President. She will oversee and support all operations for the behavioral healthcare leader. This seasoned professional brings 20+...

MEADOWS BEHAVIORAL HEALTHCARE TAPS EXPERIENCED CLINICIAN AND LEADER JAIME VINCK TO FILL PRESIDENT'S SEAT
APhA and NASPA release the first PWWR report and learnings for 2024

Today, the American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA) released the ninth installment of the Pharmacy Workplace and Well-being Reporting (PWWR) trends and...

APhA and NASPA release the first PWWR report and learnings for 2024
SeeMedX Announces Appointment of Dr. Peter Ganz to Advisory Board

SeeMedX, Inc. ("SeeMedX") today announced the appointment of Dr. Peter Ganz to its advisory board, effective immediately. Dr. Ganz is a distinguished leader in cardiology and a pioneer in clinical cardiac research,...

SeeMedX Announces Appointment of Dr. Peter Ganz to Advisory Board
Senaptec Partners with UFC Performance Institute to Make Visual Sensory Tech Available to MMA Athletes.

Senaptec, a leader in sensory performance training, announces a partnership with the UFC Performance Institute, the premier hub for MMA performance training, rehabilitation, nutrition, and sports science research. This...

Senaptec Partners with UFC Performance Institute to Make Visual Sensory Tech Available to MMA Athletes.
Matchwell and Indiana Hospital Association unveil nation's first state resource pool for flexible healthcare staffing

Matchwell, a Medical Solutions brand specializing in matching local and per diem clinicians with top healthcare facilities, is proud to announce the launch of the nation's first resource pool for flexible healthcare...

Matchwell and Indiana Hospital Association unveil nation's first state resource pool for flexible healthcare staffing
Comar Celebrates 75 Years of Innovation

Comar proudly announces its 75th anniversary as a leading contract manufacturer for healthcare companies worldwide and as a leading provider of primary packaging and dispensing products. Founded on the guiding principles...

Comar Celebrates 75 Years of Innovation
Pew Funds 10 Latin American Scientists Conducting Biomedical Research

The Pew Charitable Trusts today announced the 2024 class of the Pew Latin American Fellows Program in the Biomedical Sciences.

Pew Funds 10 Latin American Scientists Conducting Biomedical Research
OAK CREEK WOOD PRODUCTS ACHIEVES CERTIFICATION AS A MINORITY BUSINESS ENTERPRISE BY NMSDC

Oak Creek Wood Products proudly announces its certification as a Minority Business Enterprise (MBE) by the National Minority Supplier Development Council (NMSDC). This prestigious acknowledgment recognizes Oak Creek Wood...

OAK CREEK WOOD PRODUCTS ACHIEVES CERTIFICATION AS A MINORITY BUSINESS ENTERPRISE BY NMSDC
Myasthenia Gravis Foundation of America (MGFA) Launches New MGFA Helpline to Address MG-related Questions and Provide Emotional Assistance

Myasthenia Gravis Foundation of America (MGFA™), the largest, leading patient advocacy organization solely dedicated to the myasthenia gravis (MG) community, launched today the new MGFA Helpline to connect myasthenia...

Myasthenia Gravis Foundation of America (MGFA) Launches New MGFA Helpline to Address MG-related Questions and Provide Emotional Assistance
University of Colorado Anschutz Medical Campus Receives $2 Million Gift from the Ce´line Dion Foundation to Advance Research in Autoimmune Neurological Disorders

The University of Colorado Anschutz Medical Campus announced the creation of the Ce´line Dion Foundation Endowed Chair in Autoimmune Neurology, made possible by a $2 million philanthropic investment from the Ce´line Dion...

University of Colorado Anschutz Medical Campus Receives $2 Million Gift from the Ce´line Dion Foundation to Advance Research in Autoimmune Neurological Disorders
MCRA Supports 3D Systems with 510(k) FDA Clearance for VSP PEEK Cranial Implant Device

MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm is pleased to announce its role in the U.S. Food and Drug Administration's...

MCRA Supports 3D Systems with 510(k) FDA Clearance for VSP PEEK Cranial Implant Device
MedCentral Report: Facing challenges, physicians adapt with side gigs and new practice models; most not using AI

Facing the challenges of increased competition and lower reimbursement, physician practices are responding with added patient services and non-physician staffing, while they consider switching to new practice models to...

MedCentral Report: Facing challenges, physicians adapt with side gigs and new practice models; most not using AI
Alveo's Portable, Rapid Molecular Diagnostic Platform Proves Unshakable in Rigorous Ruggedness Tests

Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary technology platform, today announced the results of rigorous testing that demonstrate the ruggedness of its portable...

Alveo's Portable, Rapid Molecular Diagnostic Platform Proves Unshakable in Rigorous Ruggedness Tests
John Hancock Becomes First Life Insurer to Offer Customers Discounted Access to Prenuvo Whole-Body MRI Scans

Collaboration Expands Access to Preventative Health Innovations That Can Help John Hancock Customers Live Longer, Healthier, Better Lives™?

John Hancock Becomes First Life Insurer to Offer Customers Discounted Access to Prenuvo Whole-Body MRI Scans
Color and Carrum Health Partner to Improve Outcomes and Reduce Cost of Cancer Care for Employers

Color Health and Carrum Health today announced a partnership for an end-to-end cancer program designed to improve the care, treatment and outcomes, and reduce the financial burden of cancer for employers. Color and Carrum...

Color and Carrum Health Partner to Improve Outcomes and Reduce Cost of Cancer Care for Employers
Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trial of SPY001, its Novel Half-life Extended anti-a4ß7 Antibody, for the Treatment of Inflammatory Bowel Disease

Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches...

Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trial of SPY001, its Novel Half-life Extended anti-a4ß7 Antibody, for the Treatment of Inflammatory Bowel Disease
New report offers lessons on stopping disease outbreaks, amid global spread of H5N1

With the highly contagious H5N1 avian influenza (bird flu) spreading worldwide, Finland provides a lesson in how to bring an outbreak under control quickly. After a deadly outbreak of H5N1 was found on a fur farm last...

New report offers lessons on stopping disease outbreaks, amid global spread of H5N1
Clover Announces Positive Preliminary Phase ? Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults

Clover Biopharmaceuticals, Ltd.?(Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world, today...

Clover Announces Positive Preliminary Phase ? Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults
Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association's 84th Scientific Sessions

Gan & Lee Pharmaceuticals (Shanghai Stock Exchange: 603087) announced today the presentation of three abstracts featuring their investigational products at the American Diabetes Association's (ADA's[1]) 84th...

Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association's 84th Scientific Sessions
First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patient With Severe Stiff-Person Syndrome Published in Proceedings of the National Academy of Sciences (PNAS)

Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced today the publication in...

First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patient With Severe Stiff-Person Syndrome Published in Proceedings of the National Academy of Sciences (PNAS)
Progentec Diagnostics Announces Appointment of Immunology Expert Dr. Bernard Rubin

Progentec Diagnostics, a leader in diagnostic and digital technologies for management of autoimmune diseases, announced today that Bernard R. Rubin, DO, MPH (FACR, FACP), seasoned rheumatology and immunology expert, has...

Progentec Diagnostics Announces Appointment of Immunology Expert Dr. Bernard Rubin
Wren Laboratories Unveils Dynamic Executive Leadership Team and 2024 Commercial Strategy Overhaul

Wren Laboratories, a leader in novel in-vitro diagnostic (IVD) technologies, announced today significant enhancements to its executive leadership team. These changes aim to strengthen Wren's commercial operations and...

Wren Laboratories Unveils Dynamic Executive Leadership Team and 2024 Commercial Strategy Overhaul
Mitsubishi Tanabe Pharma America Presents New Results of RADICAVA® (edaravone) for People Living with ALS at the European Network to Cure ALS (ENCALS) Meeting 2024

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced results from two studies of RADICAVA® (edaravone) for amyotrophic lateral sclerosis (ALS) at the European Network to Cure Amyotrophic Lateral Sclerosis (ENCALS)...

Mitsubishi Tanabe Pharma America Presents New Results of RADICAVA® (edaravone) for People Living with ALS at the European Network to Cure ALS (ENCALS) Meeting 2024
Mitsubishi Tanabe Pharma America Presents Final Results from the Global, Phase 3b MT-1186-A02 Post-marketing Study of RADICAVA® (edaravone) in ALS

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of final results from the global, multi-center, double-blind, Phase 3b MT-1186-A02 study of oral edaravone in amyotrophic lateral sclerosis...

Mitsubishi Tanabe Pharma America Presents Final Results from the Global, Phase 3b MT-1186-A02 Post-marketing Study of RADICAVA® (edaravone) in ALS
CardioFlow's VitaFlow Liberty™ Granted EU CE-MDR Mark, Advancing Global Expansion Roadmap

MicroPort® CardioFlow Medtech Corporation (CardioFlow) (Stock Code: 02160.HK) recently announced that its self-developed second-generation transcatheter aortic valve implantation (TAVI) device, the VitaFlow LibertyTM...

CardioFlow's VitaFlow Liberty™ Granted EU CE-MDR Mark, Advancing Global Expansion Roadmap
New Understood.org Research Finds ADHD in Women Is Overwhelmingly Misunderstood

Understood.org, a leading nonprofit empowering more than 70 million neurodivergent people who have learning and thinking differences, such as ADHD and dyslexia, today announced the results of a Harris Poll of over 2,000...

New Understood.org Research Finds ADHD in Women Is Overwhelmingly Misunderstood
Kira Pharmaceuticals Presents Positive Results of KP104 Phase 2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Study at European Hematology Association (EHA) Congress 2024 Demonstrating Long-term Safety and Efficacy

Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced positive long-term results from its Phase 2 study of KP104 in...

Kira Pharmaceuticals Presents Positive Results of KP104 Phase 2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Study at European Hematology Association (EHA) Congress 2024 Demonstrating Long-term Safety and Efficacy
AEYE Health and Optomed to Launch Aurora AEYE: The First Portable, AI-Powered Diabetic Retinopathy Screening Solution that Provides On-the-Spot Diagnosis

AEYE Health, the leader in artificial intelligence-based diagnostics for retinal imaging, and Optomed, a leader in portable retinal devices, are proud to unveil Aurora AEYE, the first-ever portable, fully autonomous...

AEYE Health and Optomed to Launch Aurora AEYE: The First Portable, AI-Powered Diabetic Retinopathy Screening Solution that Provides On-the-Spot Diagnosis
Mitsubishi Tanabe Pharma America Celebrates Second Anniversary of RADICAVA ORS® (edaravone) Launch in the U.S.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the two-year launch anniversary of RADICAVA ORS® (edaravone) in the U.S. Since its availability in June 2022, RADICAVA ORS has been used to treat over 9,600...

Mitsubishi Tanabe Pharma America Celebrates Second Anniversary of RADICAVA ORS® (edaravone) Launch in the U.S.
Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients

SOURCE Raya Therapeutic Inc. MONTREAL, June 17, 2024 /PRNewswire/ - Raya Therapeutic Inc., ("Raya") a mission-driven company focused on the treatment of ALS and other neurodegenerative diseases, is pleased to announce supportive clinical data for its lead compound, fasudil (RT1968, in the treatment of Amyotrophic Lateral Sclerosis (ALS)), as disclosed in a conference abstract for the ENCALS meeting by the investigators of the ROCK-ALS Phase 2 clinical trial. As shared in the con...

Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients
Pharmacists' Top-Recommended Over-the-Counter Health Products for 2024 Revealed

Pharmacy Times® today released its comprehensive annual list of over-the-counter (OTC) health products most recommended by pharmacists. The 2024 OTC Guide® provides recommendations and rankings on more than 800 brands...

Pharmacists' Top-Recommended Over-the-Counter Health Products for 2024 Revealed
Neuromod's FDA-Approved Lenire Device Now a Treatment Option for 2.9 Million US Veterans with Tinnitus

Neuromod USA Inc. has been awarded a Federal Supply Schedule 65 II Medical Equipment and Supply Contract from the US Government, making the Lenire tinnitus device a treatment option for the 2.9 million US Veterans living...

Neuromod's FDA-Approved Lenire Device Now a Treatment Option for 2.9 Million US Veterans with Tinnitus
PMB partners with Riverside University Health System on a $580 million behavioral health campus in Mead Valley, California

Riverside University Health System (RUHS) and PMB broke ground on an unprecedented project, The Wellness Village in Mead Valley, that will transform healthcare by integrating behavioral health treatment with medical care...

PMB partners with Riverside University Health System on a $580 million behavioral health campus in Mead Valley, California
Subcutaneous amivantamab Biologics License Application submitted to U.S. FDA for patients with EGFR-mutated non-small cell lung cancer

Johnson & Johnson (NYSE: JNJ) announced today the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for a fixed combination of amivantamab and recombinant human...

Subcutaneous amivantamab Biologics License Application submitted to U.S. FDA for patients with EGFR-mutated non-small cell lung cancer
NAMI Membership Elects New Board of Directors During NAMICon 2024

The National Alliance on Mental Illness (NAMI) today announced the election of its new board of directors. Cathryn Nacario, CEO of NAMI San Diego and Imperial Counties, was elected to serve as board president of the...

NAMI Membership Elects New Board of Directors During NAMICon 2024
Leads Biolabs Unveils Preclinical Data on LBL-047, a Novel, First-In-Class Long-Acting TACI/Anti-BDCA2 Bispecific Antibody Fusion Protein in an Oral Presentation at EULAR 2024 Congress

At the recent European League Against Rheumatism (EULAR) Congress in Vienna, Austria, Nanjing Leads Biolabs Co., Ltd. (Leads Biolabs) delivered an oral presentation on its highly innovative therapeutic candidate LBL-047....

Leads Biolabs Unveils Preclinical Data on LBL-047, a Novel, First-In-Class Long-Acting TACI/Anti-BDCA2 Bispecific Antibody Fusion Protein in an Oral Presentation at EULAR 2024 Congress
Berberine Could Treat Eczema-Exacerbated Staphylococcus aureus Infections

Eczema, a skin inflammatory disease that causes dry, itchy and inflamed skin, affects millions worldwide. Eczema is associated with an altered skin microbiome and higher colonization by Staphylococcus aureus. The study,...

Berberine Could Treat Eczema-Exacerbated Staphylococcus aureus Infections
CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the initial results from the...

CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024
FDA Roundup: June 14, 2024

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:

FDA Roundup: June 14, 2024
FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE

Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved BLINCYTO® (blinatumomab) for the treatment of adult and pediatric patients one month or older with CD19-positive Philadelphia...

FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it has submitted an amendment to its Emergency Use Authorization to the U.S. Food and Drug...

Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
HAIR SUPPLEMENTS: ARE THEY WORTH THE HYPE? ISHRS HAIR RESTORATION EXPERTS EXAMINE THE SCIENCE BEHIND KEY INGREDIENTS IN OVER-THE-COUNTER HAIR GROWTH PRODUCTS

Despite the glowing testimonials from consumers in advertisements promoting hair supplements to combat hair loss and thinning, hair restoration experts warn that consuming supplements without getting to the root of what is...

HAIR SUPPLEMENTS: ARE THEY WORTH THE HYPE? ISHRS HAIR RESTORATION EXPERTS EXAMINE THE SCIENCE BEHIND KEY INGREDIENTS IN OVER-THE-COUNTER HAIR GROWTH PRODUCTS
TALVEY® (talquetamab-tgvs) demonstrates highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma

Johnson & Johnson (NYSE: JNJ) announced today that long-term data from the Phase 1/2 MonumenTAL-1 study showed that with 20 to 30 months of median follow-up, triple-class-exposed patients with relapsed or refractory...

TALVEY® (talquetamab-tgvs) demonstrates highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma
Arthrosi Presents Positive Phase 2 Data for AR882 at the European Alliance of Associations for Rheumatology (EULAR) Congress 2024

Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate levels, flares and tophi in patients...

Arthrosi Presents Positive Phase 2 Data for AR882 at the European Alliance of Associations for Rheumatology (EULAR) Congress 2024
A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced...

A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced today that its in-house developed innovative transcatheter pulmonic valve...

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced one oral and four poster presentations at the European Hematology Association (EHA) 2024 Hybrid Congress in Madrid, Spain being held June 13-16, 2024, and online....

Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2a-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic,...

Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2a-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary
Sphera Named a Leader in Carbon Accounting and Management Software in Latest IDC MarketScape Report

Sphera, a leading global provider of environmental, social and governance (ESG) performance and risk management software, data and consulting services, has been named a Leader in the IDC MarketScape: Worldwide Carbon...

Sphera Named a Leader in Carbon Accounting and Management Software in Latest IDC MarketScape Report
APhA statement on Supreme Court decision preserving patient access to crucial medications

The American Pharmacists Association (APhA) is pleased that the result of today's Supreme Court decision in FDA v. Alliance for Hippocratic Medicine, that the plaintiffs lacked standing, will preserve patients'...

APhA statement on Supreme Court decision preserving patient access to crucial medications
Top Kidney Patient Group Shares National Reuters Pharma Award

The American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient organization in the U.S., and Bayer were recently honored with the national 2024 Reuters Pharma Award in Driving Health...

Top Kidney Patient Group Shares National Reuters Pharma Award
Simply Healthcare Funds Mental Health Services for Families of Nicklaus Children's Hospital ICU Patients

More than 120 families of patients who have been admitted to the Nicklaus Children's Hospital's Neonatal Intensive Care Unit (NICU) and Cardiac Intensive Care Unit (CICU) this year have benefited from extra mental...

Simply Healthcare Funds Mental Health Services for Families of Nicklaus Children's Hospital ICU Patients
Get Well Named to AVIA Marketplace's 2024 Top Smart Rooms Companies

Get Well, the global leader in digital patient engagement, announced today that it was recognized as a 2024 Top Company in Smart Rooms upon conclusion of extensive research and company outreach by AVIA Marketplace, the...

Get Well Named to AVIA Marketplace's 2024 Top Smart Rooms Companies
GT Molecular Announces an Ultra-Sensitive RT-PCR Multiplex Panel for Eight Key KRAS G12-G13 Mutations

GT Molecular, Inc., a leader in developing ultra-sensitive PCR assays for cancer research, pathogen detection, and wastewater-based epidemiology testing, is adding to its cancer molecular assay product line with a...

GT Molecular Announces an Ultra-Sensitive RT-PCR Multiplex Panel for Eight Key KRAS G12-G13 Mutations
Pelvic Rehabilitation Medicine Expands Access to Care in Houston by Welcoming Zita Anigbogu

Pelvic Rehabilitation Medicine (PRM), a national leader in non-invasive pelvic pain treatment, believes when it comes to endometriosis and pelvic pain, access to care is imperative. Pelvic Rehabilitation Medicine welcomes...

Pelvic Rehabilitation Medicine Expands Access to Care in Houston by Welcoming Zita Anigbogu
March Of Dimes Awards Scholarships to Exceptional Nursing Students Committed to Improving Health Outcomes for Mom and Baby

March of Dimes, the leading nonprofit fighting for the health of all families, has awarded its 2024 March of Dimes Nursing Scholarship Awards to two outstanding nurses for their undergraduate and graduate studies....

March Of Dimes Awards Scholarships to Exceptional Nursing Students Committed to Improving Health Outcomes for Mom and Baby
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majority-owned digital...

PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease

AbbVie (NYSE: ABBV) and FutureGen Biopharmaceutical (Beijing) Co., Ltd. today announced a license agreement to develop FG-M701, a next generation TL1A antibody for the treatment of IBD currently in preclinical development.

AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease
Sterile Processing Express (SPDx) Achieves Advanced Sterile Processing Certification from DNV GL

Sterile Processing Express (SPDx) announced today that it has achieved a major milestone in its healthcare business development. SPDx has received an Advanced Sterile Processing Certification from DNV GL, a global...

Sterile Processing Express (SPDx) Achieves Advanced Sterile Processing Certification from DNV GL
Remix Therapeutics™ to Present Preclinical Data Demonstrating Anti-Tumor Activity of REM-422 in AML at the European Hematology Association (EHA) 2024 Congress

Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, will deliver a poster presentation demonstrating...

Remix Therapeutics™ to Present Preclinical Data Demonstrating Anti-Tumor Activity of REM-422 in AML at the European Hematology Association (EHA) 2024 Congress
CathCare Debuts Innovative "PortPouch" at FIME 2024, Pioneering Patient-Centric IV Care Solutions

CathCare, a women-owned business dedicated to revolutionizing patient care, is thrilled to announce the official debut of its flagship product, the PortPouch, at the Florida International Medical Expo (FIME) from June...

CathCare Debuts Innovative "PortPouch" at FIME 2024, Pioneering Patient-Centric IV Care Solutions
New CIMZIA® data for women living with chronic rheumatic diseases throughout pregnancy, and for people living with RA and high rheumatoid factor levels

UCB, a global biopharmaceutical company, will present results from three studies for CIMZIA® (certolizumab pegol), a PEGylated fragment crystalized (Fc)-free tumor necrosis factor inhibitor (TNFi), for women of...

New CIMZIA® data for women living with chronic rheumatic diseases throughout pregnancy, and for people living with RA and high rheumatoid factor levels
Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and...

Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer
Grady Reverified as Level I Trauma Center by the American College of Surgeons

Grady Memorial Hospital's Marcus Trauma Center has been reverified as a Level I trauma center by the American College of Surgeons (ACS), meeting all criteria required by ACS. This achievement recognizes Grady's...

Grady Reverified as Level I Trauma Center by the American College of Surgeons
Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter

Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal year ended April 30, 2024 on Wednesday, June 26, 2024 after the close of...

Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter
AANA Issues Policy Considerations for the Management of Waste Anesthetic Gases

(AANA)- The American Association of Nurse Anesthesiology (AANA) recently issued its policy considerations addressing the safe and effective disposal of waste anesthetic gases (WAG).

AANA Issues Policy Considerations for the Management of Waste Anesthetic Gases
Bartow Regional Medical Center Plans Expansion to Serve Growing Community

Bartow Regional Medical Center is expanding to meet the needs of a growing population.

Bartow Regional Medical Center Plans Expansion to Serve Growing Community